Data search
Results for MligTC455_32137
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_32137 | 3 | 0.06 | Mlig455_032362 | Neo: - Age: - |
PIF1 | Mlig455_032362 {REF} {Length: 1962} {Pfam: PIF1-like helicase [PF05970.16, score=22.6]} {Human: ENSG00000140451, PIF1, PIF1 5'-to-3' DNA helicase, [Score=49.3, Expect=1e-05]} {Mouse: ENSMUSG00000041064, Pif1, PIF1 5'-to-3' DNA helicase, [Score=49.7, Expect=8e-06]} {Celegans: WBGene00004028, pif-1, ATP-dependent DNA helicase PIF1, [Score=50.1, Expect=2e-06]} {RNA1509_2607} {RNA1310_5853.1} {RNA815_5517.1} |
Cumulative graph for MligTC455_32137
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | - | - | - | - | |
| RegionR2 | - | - | - | - | |
| RegionR3 | - | - | - | - | |
| RegionR4 | - | - | - | - | |
| RegionR5 | - | - | - | - | |
| RegionR6 | - | - | - | - | |
| RegionR7 | - | - | - | - | |
| RegionR8 | - | - | - | - |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | - | - | - | - | |
| RegenerationR2 | - | - | - | - | |
| RegenerationR3 | - | - | - | - | |
| RegenerationR4 | - | - | - | - | |
| RegenerationR5 | - | - | - | - | |
| RegenerationR6 | - | - | - | - | |
| RegenerationBL | - | - | - | - | |
| RegenerationTP | - | - | - | - |
Genes with expression patterns similar to MligTC455_32137
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_32137 | 3 | 0.06 | Mlig455_032362 | Neo: - Age: - |
PIF1 | 1 | - | - | - | - | 1.000 | - | Mlig455_032362 {REF} {Length: 1962} {Pfam: PIF1-like helicase [PF05970.16, score=22.6]} {Human: ENSG00000140451, PIF1, PIF1 5'-to-3' DNA helicase, [Score=49.3, Expect=1e-05]} {Mouse: ENSMUSG00000041064, Pif1, PIF1 5'-to-3' DNA helicase, [Score=49.7, Expect=8e-06]} {Celegans: WBGene00004028, pif-1, ATP-dependent DNA helicase PIF1, [Score=50.1, Expect=2e-06]} {RNA1509_2607} {RNA1310_5853.1} {RNA815_5517.1} |
| 2. | MligTC455_24950 | 10 | 0.21 | Mlig455_054045 | Neo: - |
AHNAK | 0.984 | - | - | - | - | 0.984 | - | Mlig455_054045 {REF} {Length: 4123} {Pfam: Herpes virus major outer envelope glycoprotein (BLLF1) [PF05109.15, score=23.5]; AAA domain [PF13166.8, score=18.0]} {Human: ENSG00000124942, AHNAK, AHNAK nucleoprotein, [Score=90.9, Expect=2e-17]} {Mouse: ENSMUSG00000069833, Ahnak, AHNAK nucleoprotein (desmoyokin), [Score=94.0, Expect=1e-18]} {Dmel: FBgn0259108, futsch, [Score=54.3, Expect=1e-06]} {RNA1310_26440.1} {RNA815_25850.1} |
| 3. | MligTC455_49211 | 30 | 0.63 | Mlig455_044533 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_044533 {REF} {Length: 2489} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=139.7]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=62.0, Expect=5e-10]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=51.6, Expect=1e-07]} {RNA1509_50956} {RNA1310_27155} {RNA815_39321} | |
| 4. | MligTC455_43038 | 44 | 0.92 | Mlig455_015669 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_015669 {REF} {Length: 1488} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=94.0, Expect=2e-22]} {RNA1310_25409} {RNA815_23260} | |
| 5. | MligTC455_44662 | 76 | 1.57 | Mlig455_038241 | Neo: - Age: logFC(26M/2M)=-0.868 |
ANO7 | 0.975 | - | - | - | - | 0.975 | - | Mlig455_038241 {REF} {Length: 3705} {Pfam: Calcium-activated chloride channel [PF04547.14, score=457.8]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=572, Expect=0.0]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=561, Expect=0.0]} {Dmel: FBgn0038721, subdued, [Score=420, Expect=3e-137]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=165, Expect=1e-43]} {Smed: dd_Smed_v6_19189_0_1, dd_Smed_v6_19189_0_1, [Score=659, Expect=0.0]} {RNA1509_46639} {RNA1310_1412.2} {RNA815_15650} |
| 6. | MligTC455_13733 | 48 | 1.01 | Mlig455_060487 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_060487 {REF} {Length: 1932} {RNA1310_31419} {RNA815_30794} | |
| 7. | MligTC455_13028 | 20 | 0.41 | Mlig455_004716 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_004716 {REF} {Length: 656} {NoTransDecoderORF} | |
| 8. | MligTC455_28408 | 47 | 0.98 | Mlig455_055493 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_055493 {REF} {Length: 5141} {RNA1509_42084} {RNA1310_16069} {RNA815_21447} | |
| 9. | MligTC455_54064 | 85 | 1.76 | Mlig455_002543, Mlig455_002586 | Neo: - Age: - Region-enriched R8: 4.573/0.01369 |
0.965 | - | - | - | - | 0.965 | - | Mlig455_002543 {REF} {Length: 2311} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=32.4]} {RNA1310_11536} {RNA815_6619.1} Mlig455_002586 {REF} {Length: 2383} {RNA1310_11536} {RNA815_6619.1} |
|
| 10. | MligTC455_08212 | 95 | 1.98 | Mlig455_028998 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_028998 {REF} {Length: 1315} {NoTransDecoderORF} | |
| 11. | MligTC455_26774 | 54 | 1.12 | Mlig455_038949 | Neo: - |
ANO7 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_038949 {REF} {Length: 4653} {Pfam: Calcium-activated chloride channel [PF04547.14, score=519.7]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=243.5]} {Human: ENSG00000146205, ANO7, anoctamin 7, [RH, Score=875, Expect=0.0]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [RH, Score=886, Expect=0.0]} {Dmel: FBgn0038721, subdued, [RH, Score=596, Expect=0.0]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=242, Expect=6e-68]} {Smed: dd_Smed_v6_4761_0_1, dd_Smed_v6_4761_0_1, [RH, Score=1092, Expect=0.0]} {RNA1509_15570} {RNA1310_5583.1} {RNA815_1646.1} |
| 12. | MligTC455_06458 | 109 | 2.27 | Mlig455_058915 | Neo: - Age: - |
TMEM184B | 0.955 | - | - | - | - | 0.955 | - | Mlig455_058915 {REF} {Length: 2946} {Pfam: Organic solute transporter Ostalpha [PF03619.18, score=289.5]} {Human: ENSG00000198792, TMEM184B, transmembrane protein 184B, [RH, Score=437, Expect=5e-152]} {Mouse: ENSMUSG00000009035, Tmem184b, transmembrane protein 184b, [RH, Score=432, Expect=5e-150]} {Dmel: FBgn0035236, CG12004, [RH, Score=446, Expect=2e-154]} {Celegans: WBGene00009574, F40E10.6, [RH, Score=473, Expect=2e-166]} {Smed: dd_Smed_v6_3881_1_1, dd_Smed_v6_3881_1_1, [RH, Score=461, Expect=2e-162]} {RNA1310_13503.1} {RNA815_394.1} |
| 13. | MligTC455_14577 | 51 | 1.06 | Mlig455_024026, Mlig455_024091 | Neo: - Age: logFC(26M/2M)=-0.714 |
0.954 | - | - | - | - | 0.954 | - | Mlig455_024026 {REF} {Length: 243} {NoTransDecoderORF} {RNA1310_72624} Mlig455_024091 {REF} {Length: 2685} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.7]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=64.7, Expect=1e-10]} {RNA1310_28762} {RNA815_42177} |
|
| 14. | MligTC455_09473 | 19 | 0.39 | Mlig455_050329 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_050329 {REF} {Length: 660} {NoTransDecoderORF} {RNA1509_9817} {RNA1310_86966} {RNA815_34606} | |
| 15. | MligTC455_33637 | 187 | 3.9 | Mlig455_027211, Mlig455_027458 | Neo: - Age: - Region-enriched R2: 3.458/0.04514 |
CHRNA10, CHRNA7 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2} Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2} |
Berezikov Lab - 2020-2021 © ERIBA